Companies / Valence Discovery
AI-first drug design (now Valence Labs within Recursion).
Investors listed on their own portfolio pages or in reported coverage. Round details are not tracked in the Index.
Brightspark Ventures, Panache Ventures, Real Ventures
Data as of September 26, 2026. Suggest a correction